Insulin prices have sparked outrage in recent months, with Congress holding hearings on the issue and launching bipartisan investigations into why the cost of the hormone used to treat diabetes – discovered nearly a century ago – has soared over the past two decades. The House Energy and Commerce oversight subcommittee held a hearing on insulin prices this week and will hold another next week. Executives from the three companies that dominate the global insulin market – Eli Lilly, Novo Nordisk and Sanofi – are expected to testify at the upcoming hearing. “We want to know why the cost of …read more
Source: Sott health news feed
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr